Ji‐Youn Han
- Oncology top 0.1%
- Lung Cancer Research Studies 75
- Colorectal Cancer Treatments and Studies 46
- Cancer Immunotherapy and Biomarkers 26
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 182
- Lung Cancer Diagnosis and Treatment 56
- Gastric Cancer Management and Outcomes 16
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 40
- Immunology top 2%
-
- Cancer therapeutics and mechanisms 29
- Co-authors
- Myung‐Ju AhnMargarita MajemDong‐Wan KimEdward B. GaronRoy S. HerbstPaul BaasJosé Luis Perez‐GraciaJoo-Hang Kim
- Journals
- Journal of Clinical Oncology (54 papers)Journal of Thoracic Oncology (28 papers)Lung Cancer (20 papers)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Ji‐Youn Han
248 papers receiving 13.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 9.6k
- Pulmonary and Respiratory Medicine 8.2k
- Cancer Research 2.1k
- Immunology 1.3k
- Pathology and Forensic Medicine 837
Countries citing papers authored by Ji‐Youn Han
This map shows the geographic impact of Ji‐Youn Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji‐Youn Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji‐Youn Han more than expected).
Fields of papers citing papers by Ji‐Youn Han
This network shows the impact of papers produced by Ji‐Youn Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji‐Youn Han. The network helps show where Ji‐Youn Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ji‐Youn Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 22 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 16 | |
| 12 | Osimertinib + Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor–Mutated, MET -Amplified Non–Small Cell Lung Cancer: TATTONbreakdown → | 2022 | 95 |
| 13 | 2022 | 3 | |
| 14 | 2021 | 3 | |
| 15 | Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study | 2020 | 8 |
| 16 | 2020 | 13 | |
| 17 | 2020 | 27 | |
| 18 | 2018 | 24 | |
| 19 | CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non–Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)breakdown → | 2018 | 349 |
| 20 | 2011 | 64 |
About Ji‐Youn Han
Ji‐Youn Han is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 257 papers that have together received 13.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (182 papers), Lung Cancer Research Studies (75 papers), Lung Cancer Diagnosis and Treatment (56 papers), Colorectal Cancer Treatments and Studies (46 papers), Cancer Genomics and Diagnostics (40 papers), Cancer therapeutics and mechanisms (29 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Gastric Cancer Management and Outcomes (16 papers). The work is most often cited by research in Oncology (9.6k citations), Pulmonary and Respiratory Medicine (8.2k citations) and Cancer Research (2.1k citations). Ji‐Youn Han has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Myung‐Ju Ahn, Margarita Majem, Dong‐Wan Kim, Edward B. Garon, Roy S. Herbst, Paul Baas, José Luis Perez‐Gracia, Joo-Hang Kim, Gregory M. Lubiniecki and Enriqueta Felip. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Lung Cancer, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.